PlainMeds provides educational information only. This is not medical advice. Always consult your doctor or pharmacist.

adalimumab vs metoprolol

Side-by-side comparison of adalimumab and metoprolol. Data from FDA drug databases (Orange Book, NDC Directory, recalls, shortages) covering 20,000+ approved drugs, plus CMS pricing; see our methodology.

Drug Class
adalimumab TNF-Alpha Inhibitor (Biologic)
metoprolol Beta-Blocker
Type
adalimumab Prescription
metoprolol Prescription
Summary
adalimumab

Idacio is a medicine that blocks a protein called TNF. It is used to treat several diseases, including arthritis and Crohn's disease.

metoprolol

Metoprolol is a beta-blocker medicine. It can lower blood pressure, reduce chest pain, and improve survival after a heart attack.

What It Treats
adalimumab

Idacio can help adults with rheumatoid arthritis by reducing joint pain and damage. It can also help children (2 years and older) with juvenile idiopathic arthritis. Idacio treats psoriatic arthritis, ankylosing spondylitis, Crohn’s disease, ulcerative colitis, plaque psoriasis, hidradenitis suppurativa and uveitis.

metoprolol

Metoprolol treats high blood pressure (hypertension). Lowering blood pressure reduces the risk of strokes and heart attacks. It also treats chest pain called angina. After a heart attack, it can help you live longer.

How It Works
adalimumab

Idacio works by blocking a protein in your body called tumor necrosis factor (TNF). TNF can cause inflammation and damage in certain diseases. By blocking TNF, Idacio can reduce these symptoms.

metoprolol

Metoprolol blocks the effects of adrenaline on the heart. This makes the heart beat slower and with less force. As a result, blood pressure is lowered and the heart does not need as much oxygen.

Common Side Effects
adalimumab
  • Infections (like colds or sinus infections)
  • Injection site reactions (redness, itching, pain, or swelling)
  • Headache
  • Rash
metoprolol
  • Tiredness
  • Dizziness
  • Depression
  • Shortness of breath
  • Slow heart rate
FAERS Reports
adalimumab
  • Pain 49,062
  • Joint pain 48,041
  • Pain at the injection site 47,251
  • Tiredness 39,113
  • Rheumatoid arthritis 35,571
metoprolol
  • Tiredness 15,963
  • Shortness of breath 14,131
  • Diarrhea 13,634
  • Feeling sick to your stomach 13,392
  • Feeling lightheaded 11,697
Serious Warnings
adalimumab

Idacio can increase your risk of serious infections that could lead to hospitalization or death. Tell your doctor if you have any infections before starting Idacio. Idacio may also increase your risk of certain cancers, including lymphoma. Children and teens taking TNF blockers like Idacio have developed rare, aggressive cancers.

metoprolol

Stopping metoprolol suddenly can make chest pain worse or cause a heart attack. If you have heart failure, it could get worse. If you have asthma or other lung problems, avoid beta-blockers if possible.

Pregnancy
adalimumab

Tell your doctor if you are pregnant or plan to become pregnant. Idacio can cross the placenta and may affect your baby's immune system. Talk to your doctor about vaccines for your baby if you took Idacio during pregnancy.

metoprolol

Tell your doctor if you are pregnant or plan to become pregnant. Metoprolol can cross the placenta, and may cause low blood pressure, low blood sugar, and a slow heart rate in the newborn. Talk to your doctor about the risks and benefits.

Also Compare, Nearby Drugs

How to Read This adalimumab vs metoprolol Comparison

adalimumab is classified in the TNF-Alpha Inhibitor (Biologic) drug class, while metoprolol sits within the Beta-Blocker class. Drugs from different classes work through distinct mechanisms, so a head-to-head comparison illustrates trade-offs rather than equivalence. Both drugs are prescription-only, so a licensed provider must authorize use.

Adverse event totals above are pulled from the FDA's Adverse Event Reporting System (FAERS). For these top-ranked reactions alone, adalimumab has 219,038 submissions while metoprolol has 68,817. Those figures reflect cumulative reporting volume, not per-patient risk, so older, widely dispensed drugs typically look worse on count alone. No direct interaction between these two drugs is listed in our FDA-derived dataset, though co-prescription still warrants pharmacist review. Serious warnings, pregnancy guidance, and contraindications can differ even when indications overlap.

A table cannot substitute for clinical judgment. Effectiveness, tolerability, drug-drug interactions with your other medications, kidney and liver function, pregnancy status, insurance formulary, and price all feed into a decision that only a licensed prescriber can make responsibly. Data here is sourced from FDA Structured Product Labels (SPL) and FAERS, both of which update as manufacturers and clinicians submit new information. This page is for educational purposes only, is not medical advice, and should not be used to self-switch between adalimumab and metoprolol - always consult your physician or pharmacist first.

Important: This comparison is for informational purposes only. Drug effects vary between individuals. Always consult your doctor or pharmacist for personalized medical advice.